Clinical trials
Uterine Cervical Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
83 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 7 |
| 2020 | 9 |
| 2021 | 13 |
| 2022 | 7 |
| 2023 | 6 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 17 |
| Active, not recruiting | 15 |
| Terminated | 10 |
| Unknown status | 8 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 6 |
| AstraZeneca | 4 |
| Eli Lilly and Company | 4 |
| Seagen Inc. | 4 |
| Seagen, a wholly owned subsidiary of Pfizer | 4 |
| Hoffmann-La Roche | 3 |
| Agenus Inc. | 2 |
| Daiichi Sankyo | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 83 |
| Ovarian Neoplasms | 29 |
| Endometrial Neoplasms | 28 |
| Carcinoma, Non-Small-Cell Lung | 24 |
| Squamous Cell Carcinoma of Head and Neck | 20 |
| Triple Negative Breast Neoplasms | 18 |
| Melanoma | 17 |
| Stomach Neoplasms | 17 |
| Esophageal Neoplasms | 14 |
| Colorectal Neoplasms | 12 |
Trials
Showing 51 to 75 of 83. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.